[Controversies on antibiotics for common group A streptococcus infections].
Management of common group A streptococcus (GAS) infections remains controversial. French recommendations advocate systematic treatment of streptococcal tonsillitis after confirmation by rapid diagnostic test. Oral amoxicillin twice daily for 6 days is the first-line treatment. Antibiotic prophylaxis is restricted to at-risk patients after contact with invasive GAS case. These recommendations take into consideration the prevention of complications, even if they are rare, the reduction of infectiousness and the reduction of the duration of symptoms. Different recommendations have been issued in other countries, particularly in Europe and are based on different considerations. These differences do not originate in the absence of demonstrative scientific studies but rather in societal considerations, themselves guided by the history of each different health system (and also judicial system). This is probably necessary to obtain physicians and public support. The French attitude reflects these considerations. However, its lack of enforcement needs to question about its origins.